Premium Information is available for this item - Upgrade for $1 a day
6515-01-505-1801
Intravenous Container
6515015051801 015051801 7222-18
An item, partially filled with solutions, used for mixing parenteral nutrition additives. May be nonmetallic construction, flexible, drug compatible and shatterproof. View more Intravenous Container
January 2023
2
Marketplace 6515-01-505-1801
Request a Quotation from participating marketplace vendors
Related Documents 6515-01-505-1801 4+ Documents (More...)
Restrictions 6515-01-505-1801
6515-01-505-1801 is a Intravenous Container that does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application. Demilitarization of this item has been confirmed and is not currently subject to changes. This item is considered a low risk when released from the control of the Department of Defense. The item may still be subject to the requirements of the Export Administration Regulations (EAR) and the Code of Federal Regulations (CFR). This item is not suspected to be hazardous. This item does not contain a precious metal.
Import and Export 6515-01-505-1801
- Schedule B
- Subscribe to View Schedule B
- HTS Code
- Subscribe to View HTS Code
End Users 6515-01-505-1801
- Turkey (ZW01)
- Effective Date:
- 1 Feb 2003
Approved Sources 6515-01-505-1801
- Part Number
- Manufacturer
- Status
- 7222-18
- Manufacturer
- 60060 - Abbott Laboratories Inc. (Active)
- Primary Buy
- Primary Buy
- 7222-18
- 33110 - Abbott Laboratories Inc. (Active)
- Secondary Buy
- Secondary Buy
Datasheet 6515-01-505-1801
- Characteristic
- Specifications
- FIIG
- Specifications
- T117-B
- Special Features [FEAT]
- Empty Three-In-One Mixing Container With Attached 3-Lead Transfer Set; Applicable For 2-In-1 Or 3-In-1 (Lf); Clamp Included; 3000Ml
NATO Stock Numbers Related to 6515-01-505-1801
Freight Information 6515-01-505-1801
6515-01-505-1801 has freight characteristics managed by Turkey.. 6515-01-505-1801 has a variance between NMFC and UFC when transported by rail and the description should be consulted.